N. Barjesteh, B. Shojadoost, J. T. Brisbin, M. Emam, D. C. Hodgins et al., Reduction of avian influenza virus shedding by administration of Toll-like receptor ligands to chickens, Vaccine, vol.33, pp.4843-4852, 2015.

M. Blanc, W. Y. Hsieh, K. A. Robertson, K. A. Kropp, T. Forster et al., The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response, Immunity, vol.38, pp.106-124, 2013.

A. L. Brass, I. C. Huang, Y. Benita, S. P. John, M. N. Krishnan et al.,

S. J. Elledge, The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus, Cell, vol.139, pp.1243-54, 2009.

C. M. Collazo, G. S. Yap, G. D. Sempowski, K. C. Lusby, L. Tessarollo et al., Vande Woude, the respiratory and intestinal mucosal surfaces and is produced after systemic administration of flagellin in mice, 2010.

. Kinnebrew, In our study, although we confirmed the IL-22 production after flagellin administration, IL-22-deficient mice still managed to reduce M1 RNA upon flagellin treatment, 2012.

A. L. Brass, I. C. Huang, Y. Benita, S. P. John, M. N. Krishnan et al.,

S. J. Elledge, The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus, Cell, vol.139, pp.1243-54, 2009.

C. M. Collazo, G. S. Yap, G. D. Sempowski, K. C. Lusby, L. Tessarollo et al., Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection, J Exp Med, vol.194, pp.181-189, 2001.

C. D. Conrady, M. Zheng, K. A. Fitzgerald, C. Liu, and D. J. Carr, Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16, Mucosal Immunol, vol.5, pp.173-83, 2012.

A. Didierlaurent, J. Goulding, S. Patel, R. Snelgrove, L. Low et al., Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection, J Exp Med, vol.205, pp.323-332, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00227540

A. E. Fiore, A. Fry, D. Shay, L. Gubareva, J. S. Bresee et al., Antiviral agents for the treatment and chemoprophylaxis of influenza ---recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, vol.60, pp.1-24, 2011.

D. Fougeron, L. Van-maele, P. Songhet, D. Cayet, D. Hot et al., Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tract, Vaccine, vol.33, pp.3331-3372, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01182907

Y. Furuse, A. Suzuki, T. Kamigaki, and H. Oshitani, Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis, Virol J, vol.6, p.67, 2009.

E. A. Govorkova, T. Baranovich, P. Seiler, J. Armstrong, A. Burnham et al., Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring, Antiviral Res, vol.98, pp.297-304, 2013.

H. Guo and D. J. Topham, Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection, J Virol, vol.84, pp.7750-7759, 2010.

D. M. Hammerbeck, G. R. Burleson, C. J. Schuller, J. P. Vasilakos, M. Tomai et al., Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats, Antiviral Res, vol.73, pp.1-11, 2007.

R. E. Hancock, A. Nijnik, and D. J. Philpott, Modulating immunity as a therapy for bacterial infections, Nat Rev Microbiol, vol.10, pp.243-54, 2012.

S. Hatakeyama, Y. Sakai-tagawa, M. Kiso, H. Goto, C. Kawakami et al., Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor, J Clin Microbiol, vol.43, pp.4139-4185, 2005.

M. Hedayat, M. G. Netea, and N. Rezaei, Targeting of Toll-like receptors: a decade of progress in combating infectious diseases, Lancet Infect Dis, vol.11, pp.702-714, 2011.

T. Horimoto and Y. Kawaoka, Influenza: lessons from past pandemics, warnings from current incidents, Nat Rev Microbiol, vol.3, pp.591-600, 2005.

M. S. Hossain, S. Ramachandiran, A. T. Gewirtz, and E. K. Waller, Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice, PLoS One, vol.9, p.96165, 2014.

I. C. Huang, C. C. Bailey, J. L. Weyer, S. R. Radoshitzky, M. M. Becker et al., Distinct patterns of IFITMmediated restriction of filoviruses, SARS coronavirus, and influenza A virus, PLoS Pathog, vol.7, 2011.

S. Ivanov, J. Renneson, J. Fontaine, A. Barthelemy, C. Paget et al., Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection, J Virol, vol.87, pp.6911-6935, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00926618

A. Iwasaki and P. S. Pillai, Innate immunity to influenza virus infection, Nat Rev Immunol, vol.14, pp.315-343, 2014.

I. Jarchum, M. Liu, L. Lipuma, and E. G. Pamer, Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis, Infect Immun, vol.79, pp.1498-503, 2011.

T. Jiang, H. Zhao, X. F. Li, Y. Q. Deng, J. Liu et al., CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model, Antiviral Res, vol.89, pp.124-130, 2011.

T. Kawai and S. Akira, The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat Immunol, vol.11, pp.373-84, 2010.

M. A. Kinnebrew, C. Ubeda, L. A. Zenewicz, N. Smith, R. A. Flavell et al., Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycinresistant Enterococcus infection, J Infect Dis, vol.201, pp.534-577, 2010.

M. A. Kinnebrew, C. G. Buffie, G. E. Diehl, L. A. Zenewicz, I. Leiner et al., Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense, Immunity, vol.36, pp.276-87, 2012.

Y. F. Lau, L. H. Tang, E. E. Ooi, and K. Subbarao, Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice, Virology, vol.406, pp.80-87, 2010.

M. M. Leiva-juarez, C. T. Kirkpatrick, B. E. Gilbert, B. Scott, M. J. Tuvim et al., Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir, Eur J Pharmacol, vol.818, pp.191-197, 2018.

D. J. Lenschow, C. Lai, N. Frias-staheli, N. V. Giannakopoulos, A. Lutz et al., IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses, Proc Natl Acad Sci U S A, vol.104, pp.1371-1377, 2007.

S. Y. Liu, R. Aliyari, K. Chikere, G. Li, M. D. Marsden et al., Interferoninducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol, Immunity, vol.38, pp.92-105, 2013.

L. Meyer, O. Leymarie, C. Chevalier, E. Esnault, M. Moroldo et al., Transcriptomic profiling of a chicken lung epithelial cell line (CLEC213) reveals a mitochondrial respiratory chain activity boost during influenza virus infection, PLoS One, vol.12, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01605882

E. J. Mifsud, A. C. Tan, and D. C. Jackson, TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease. Front Immunol 5, 79, 1006.

E. J. Mifsud, A. C. Tan, P. C. Reading, and D. C. Jackson, Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam(2)Cys, Immunol Cell Biol, vol.94, pp.169-76, 2016.

D. J. Morales and D. J. Lenschow, The antiviral activities of ISG15, J Mol Biol, vol.425, pp.4995-5008, 2013.

M. Mordstein, G. Kochs, L. Dumoutier, J. .. Renauld, S. R. Paludan et al., Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses, PLoS Pathog, vol.4, p.1000151, 2008.

N. Munoz, L. Van-maele, J. M. Marques, A. Rial, J. C. Sirard et al., Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection, Infect Immun, vol.78, pp.4226-4259, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00520159

C. Nempont, D. Cayet, M. Rumbo, C. Bompard, V. Villeret et al., Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity, J Immunol, vol.181, pp.2036-2079, 2008.

E. B. Norton, J. D. Clements, T. G. Voss, and L. Cardenas-freytag, Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model, J Virol, vol.84, pp.2983-95, 2010.

C. Paget, S. Ivanov, J. Fontaine, J. Renneson, F. Blanc et al., Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages, J Biol Chem, vol.287, pp.8816-8845, 2012.

R. Porte, D. Fougeron, N. Munoz-wolf, J. Tabareau, A. F. Georgel et al., A Toll-Like Receptor, vol.5, 2015.

, Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza VirusAssociated Pneumococcal Mouse Infections, Antimicrob Agents Chemother, vol.59, pp.6064-72

J. S. Rossman and R. A. Lamb, Influenza virus assembly and budding, Virology, vol.411, pp.229-265, 2011.

A. Savva and T. Roger, Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases, Front Immunol, vol.4, p.387, 2013.

A. C. Tan, E. J. Mifsud, W. Zeng, K. Edenborough, J. Mcvernon et al., Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice, Mol Pharm, vol.9, pp.2710-2718, 2012.

M. J. Tuvim, B. E. Gilbert, B. F. Dickey, and S. E. Evans, Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia, 1117.

L. Van-maele, C. Carnoy, D. Cayet, P. Songhet, L. Dumoutier et al., TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa, J Immunol, vol.185, pp.1177-85, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00495564

L. Van-maele, D. Fougeron, L. Janot, A. Didierlaurent, D. Cayet et al.,

Y. Lemoine, F. Erard, D. Hot, T. Hussell, B. Ryffel et al., Airway structural cells regulate TLR5-mediated mucosal adjuvant activity, Mucosal Immunol, vol.7, pp.489-500, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00925663

L. Van-maele, C. Carnoy, D. Cayet, S. Ivanov, R. Porte et al., Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection, J Infect Dis, vol.210, pp.493-503, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01182903

A. Vijayan, M. Rumbo, C. Carnoy, and J. C. Sirard, Compartmentalized Antimicrobial Defenses in Response to Flagellin, Trends Microbiol, vol.26, pp.423-435, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01671191

F. Villalon-letelier, A. G. Brooks, P. M. Saunders, S. L. Londrigan, and P. C. Reading, Host Cell Restriction Factors that Limit Influenza A Infection, 2017.

X. Wang, E. R. Hinson, and P. Cresswell, The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts, Cell Host Microbe, vol.2, pp.96-105, 2007.

J. P. Wong, M. E. Christopher, S. Viswanathan, N. Karpoff, X. Dai et al., Activation of toll-like receptor signaling pathway for protection against influenza virus infection, Vaccine, vol.27, pp.3481-3484, 2009.

C. C. Wu, T. Hayashi, K. Takabayashi, M. Sabet, D. F. Smee et al., Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand, Proc Natl Acad Sci U S A, vol.104, pp.3990-3995, 2007.

F. S. Yu, M. D. Cornicelli, M. A. Kovach, M. W. Newstead, X. Zeng et al., Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide, J Immunol, vol.185, pp.1142-1151, 2010.

B. Zhang, B. Chassaing, Z. Shi, R. Uchiyama, Z. Zhang et al., Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18, Science, vol.346, pp.861-866, 1122.
URL : https://hal.archives-ouvertes.fr/hal-01290555

J. Zhao, C. Wohlford-lenane, J. Zhao, E. Fleming, T. E. Lane et al., Intranasal treatment with poly(I*C) protects aged mice from lethal respiratory virus infections, J Virol, vol.86, pp.11416-11440, 1353.

. Georgel, Twelve hours before infection and 12 and 36h post-infection, mice received 5 µg of flagellin intraperitoneally. Lungs were sampled 24 and 48 h post-infection (12h post-flagellin administration) and mRNA was quantified by RT-qPCR. (B, D) The relative gene expression was normalized to the expression of PBS-treated animals (arbitrarily set to a value of 1. Results are represented as the median with standard deviation, Supplementary figure Supplementary figure: Flagellin treatment does not activate expression of IL-18 encoding gene